Biggest News Aggregation in the World
📰 Immunic News

Page 6 - Immunic News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Immunic. Real-time updates on events, politics, business and more.

EQS-News: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.

Issuer: Immunic, Inc. / Key word(s): Personnel Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D. 27.04.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic, Inc. Strengthens Its Board of Directors with th...
United States Jessica Breu Vincent Ossipow Paula Schwartz Duane Nash Edna Kaplan

Contrasting (RAMP) & Its Rivals | Daily Political

Immunic, Inc. (NASDAQ:IMUX – Get Rating) has received a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The […]
Immunic Inc Immunic Company Profile Dimensional Fund Advisors Metlife Investment Management Blackrock Inc Jpmorgan Chase Co

Immunic, Inc. (NASDAQ:IMUX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Immunic, Inc. (NASDAQ:IMUX – Get Rating) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the company. The […]
Jpmorgan Chase Co Marshall Wace Immunic Company Profile Denali Advisors Immunic Inc Metlife Investment Management
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

EQS-News: Immunic, Inc.: Immunic Reports Positive Data from Maintenance Phase of Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Moderate-to-Severe Ulcerative Colitis

Issuer: Immunic, Inc. / Key word(s): Study results/Strategic Company Decision Immunic Reports Positive Data from Maintenance Phase of Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Moderate-to-Severe
United States Paula Schwartz Andreas Muehler Deprioritize Izumerogant Jessica Breu Edna Kaplan

Immunic, Inc. (NASDAQ:IMUX) Receives $22.00 Consensus Price Target from Analysts

Shares of Immunic, Inc. (NASDAQ:IMUX – Get Rating) have been assigned an average rating of “Moderate Buy” from the six research firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating on […]
Immunic Inc Vanguard Group Inc Gratus Capital Blackrock Inc Artal Group Immunic Company Profile

EQS-News: Immunic to Participate in Investor and Scientific Conferences in March

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in March 02.03.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Investor and Scientific Conferences in March NEW YOR...
United States New Orleans Germany General Edna Kaplan Paula Schwartz Biocapital Europe

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science